• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anika Therapeutics Inc

+ Add to Watchlist


40.6100 USD 0.6000 1.46%

As of 17:20:00 ET on 08/21/2014.

Snapshot for Anika Therapeutics Inc (ANIK)

Open: 41.0300 Day's Range: 40.3300 - 41.2600 Volume: 196,533
Previous Close: 41.2100 52wk Range: 22.8500 - 52.4900 1-Yr Rtn: +72.81%

Stock Chart for ANIK

No chart data available.
  • ANIK:US 40.6100
  • 1D
  • 1M
  • 1Y
Interactive ANIK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANIK

Current P/E Ratio (ttm) 17.3680
Estimated P/E(12/2014) 17.2809
Relative P/E vs. SPX 0.9740
Earnings Per Share (USD) (ttm) 2.3382
Est. EPS (USD) (12/2014) 2.3500
Est. PEG Ratio 0.5760
Market Cap (M USD) 588.30
Shares Outstanding (M) 14.49
30 Day Average Volume 323,407
Price/Book (mrq) 3.7006
Price/Sale (ttm) 5.8624
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANIK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANIK

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The Company's products, based on hyaluronic acid, promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika's products include ORTHOVISC and HYVISC which treat osteoarthritis.

Charles H SherwoodPresident/CEOSylvia CheungCFO/Treasurer/Secretary
Carol A BarnettChief Commercial OfficerJohn W Sheets JrChief Scientific Officer
More Company Profile & Key Executives for ANIK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil